This spring, Hoosier Cancer Research Network Chairman Christopher A. Fausel, PharmD, invited friends and colleagues to join him in a unique challenge. For the third consecutive year, Fausel added value to his participation in the Arnold Sports Festival’s 5K Pump and Run event, held March 5 in Columbus, Ohio, by inviting pledges in support of HCRN for every bench press repetition he completed.
Twenty-eight donors answered the challenge, contributing a total of $3,315 as Fausel successfully completed 30 repetitions during the event. Since 2015, Reps for Research has raised more than $8,000 toward innovative cancer research. This funding strengthens HCRN’s ability to support investigator-initiated clinical trials and correlative research that can lead to direct clinical benefit.
“Correlative research allows physicians to examine blood samples and tissue samples in our clinical trial population to determine if there’s a way to assess why one patient responds better to the same treatment than another patient or group of patients,” Fausel said. “Those are critical questions to answer when it comes to advancing the science of cancer treatment.”
HCRN would like to thank all who contributed to Reps for Research 2017. Your gifts make a difference!
About Hoosier Cancer Research Network:
Hoosier Cancer Research Network (formerly known as Hoosier Oncology Group) conducts innovative cancer research in partnership with academic and community physicians and scientists across the United States and internationally. The organization provides comprehensive clinical trial management and support, from conception through publication. Created in 1984 as a program of the Walther Cancer Institute, Hoosier Cancer Research Network became an independent nonprofit clinical research organization in 2007. Since its founding, Hoosier Cancer Research Network has initiated more than 160 trials in a variety of cancer types and supportive care, resulting in more than 300 publications. More than 5,000 subjects have participated in Hoosier Cancer Research Network clinical trials.
